Q: how is this company doing some interesting tech do they have any competition thank you
5i Research Answer:
OTC is tiny, and has no revenue yet, so is very hard to analyse. It has losses and negative cash flow, and is going to need more capital. We have very little information on it. It is developing vision-enhancing products, and this in general is a crowded field with lots of competition. We note that OTC spent less than $1M on research last year, and may have a hard time competing against giant eye-care companies. Insiders own 6% directly and 36% indirectly.